Boris Johnson discusses when vaccine impact will be visible
When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.
UK RECOVERY, the world’s biggest Covid trial has found a combination of two drugs can reduce deaths of Covid patients on oxygen by around a third. Drugs dexamethasone & tocilizumab have been studied as part of the trial and found to have results when taken together.
Dexamethasone costs £5 per patient, while tocilizumab costs £500 for a one off infusion.
This compares to the cost of keeping patients in the ICU, which is £2000 a day.
In a study published in the US National Library of Medicine, tocilizumab drug was further analsyed.
The study noted: “The overall objective of the study is to determine the therapeutic effect and tolerance of Tocilizumab combined with Dexamethasone in patients with moderate, severe pneumonia or critical pneumonia associated with Coronavirus disease 2019 (COVID-19).
“Tocilizumab was found to inhibit the signal transduction.
“Tocilizumab will be administered to consenting adult patients hospitalized with COVID-19 either diagnosed with moderate or severe pneumonia requiring no mechanical ventilation or critical pneumonia requiring mechanical ventilation.”
This is a developing story, please refresh for updates…
Source: Read Full Article